Learn more about whether BioCryst Pharmaceuticals, Inc. or Catalyst Pharmaceuticals, Inc. is a better investment based on ...

Learn more about whether BioCryst Pharmaceuticals, Inc. or Avidity Biosciences, Inc. is a better investment based on AAII's ...

The Bay Area's biotech industry faces an uncertain future after 50 years. But industry leaders see a history of resilience ...

The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving insulin.

Treated with an individualized gene-editing therapy that corrects mutations directly on the genome, a patient shows ...

PDS Biotechnology Corporation (NASDAQ: PDSB) Q1 2025 Earnings Call Transcript May 14, 2025 PDS Biotechnology Corporation ...

Researchers are analyzing the bug oil’s bioactive properties, aiming to validate its safety and expand its promising ...

At stake in the ongoing patent dispute over the gene-editing tool are rights to the most important new biotechnology of the ...

Excessively long approval timelines and outdated regulations designed for chemicals are harming Europe’s competitive edge in ...

Genentech, a member of the Roche Group, will create 400 jobs with a new biotechnology facility in Holly Springs, Wake County, ...

Vikas Goyal, MBA, promoted to Partner to lead growth stage investments in late preclinical and clinical stage biotechnology companies. BOSTON, MASSACHUSETTS / ACCESS Newswire / May 12, 2025 / Longwood ...

Despite biotech's struggles, quality and global diversification create opportunities in select names. Read why portfolio ...